Human telomerase reverse transcriptase (hTERT), the catalytic subunit of telomerase, plays a pivotal role in the maintenance of telomeres and cell proliferation. Here we report that down-regulation of hTERT induces apoptosis independently of telomerase enzymatic activity in human breast cancer cells. Expression of a hTERT mutant lacking telomerase activity rescues the cells with lowered telomerase without inducing cell death. With similar patterns of subcellular distribution to that of the tumor suppressor protein p53 during mitosis, hTERT interacts with p53 and poly(ADP-ribose) polymerase (PARP). Decreasing p53 expression in intact cells worsens, and increasing p53 prevents, cell death induced by lowering hTERT. Thus, hTERT maintains cell survival and proliferation via both telomerase enzymatic activitydependent telomere lengthening and enzymatic activityindependent intermolecular interactions involving p53 and PARP.
Introduction
Telomerase is a large ribonucleoprotein complex that stabilizes and extends telomeres of eukaryotic chromosomes, and thereby regulates cell replicative potential and lifespan (for reviews, see Blackburn, 1992; de Lange and Jacks, 1999; Greider, 1995; Lingner and Cech, 1998; Liu, 1999; Shay and Bacchetti, 1997) . These molecular and cellular functions of telomerase are fundamental in the genesis, development, degeneration and regeneration of human tissues, organs and the body as a whole. Activation of telomerase is associated with proliferation of embryonic cells during development, activation of immune cells, expansion of bone marrow blood cell progenitors and immortalization of neoplastic cells, whereas inhibition of telomerase is implicated in cellular senescence, apoptosis, premature aging and degenerative disease (Hahn et al., 1999; Mitchell et al., 1999; Wyllie et al., 2000; Zhang et al., 1999) .
Human telomerase is composed of an RNA subunit and several protein components. The RNA subunit (hTR) contains the template for telomeric DNA and is essential for telomerase activity Prescott and Blackburn, 2000) , whereas the protein components include the catalyst telomerase reverse transcriptase (hTERT) and telomerase-associated protein 1 (hTEP1). hTR and hTEP1 are widely expressed in normal human tissues, whereas hTERT is expressed concomitantly with the activation of telomerase during cellular immortalization (Harrington et al., 1997; Kilian et al., 1997; Lingner et al., 1997; Meyerson et al., 1997; Nakamura et al., 1997; Nakayama et al., 1998) . Ectopic expression of hTERT in otherwise mortal human cells induces telomerase activation, telomere elongation and continuous cell proliferation, implicating hTERT as rate limiting for telomerase activity and playing a key role in telomerase cellular function (Bodnar et al., 1998; Counter et al., 1998; Wen et al., 1998) . Inhibition of telomerase by targeting hTR results in erosion of telomeres, compromise of growth capacity and apoptosis of highly proliferative cells (Hahn et al., 1999; Lee et al., 1998; Rudolph et al., 1999) . Inhibition of telomerase activity by targeting hTERT also induces gradual loss of telomeres, genomic instability, telomere ± telomere fusion and aneuploidy, with an increase in abnormal mitosis and apoptosis (Zhang et al., 1999) .
Studies also suggest that telomerase enzymatic activity does not always correlate with telomere maintenance and elongation (for reviews, see (Blackburn, 2000; Liu, 2000 Liu, , 2001 ). For example, alteration of the carboxyl terminus of hTERT without aecting telomerase activity disables the enzyme to maintain telomeres (Counter et al., 1998) and telomerase with enzymatic activity extends the lifespan of transformed cells without telomere lengthening (Zhu et al., 1999) . The dierence between telomerase enzymatic activity and telomere maintenance may thus reside at least partly in complex molecular interactions of hTERT protein. To explore actions of hTERT in the present study, we transiently expressed hTERT antisense RNA and a dominant negative mutant and compared their cellular eects on cell survival and apoptosis in breast cancer cell cultures. We found that lowering hTERT expression induced apoptosis independently of telo-mere shortening, and that the hTERT mutant lacking telomerase enzymatic activity rescued the cells with lowered telomerase activity from entering apoptosis. In addition, with similar subcellular distribution patterns to that of hTERT throughout mitosis, p53 is able to determine the fate of cells with decreased telomerase to survival or apoptosis. Our ®ndings suggest that hTERT operates to regulate cell survival over and above the catalytic activity of telomerase on telomeric DNA reverse transcription by intermolecular interactions within and beyond telomerase ribonucleoprotein complex.
Results
Forced transient overexpression of hTERT wild type expression constructs in human breast cancer PMC42 cells resulted in increased cellular levels of telomerase activity, two or three times that in vector transfected control cells, when assayed with the same numbers of cells or with the same amounts of cellular protein at 15 h after transfection ( Figure 1a ). In contrast, transient ectopic expression of hTERT antisense expression constructs, or of a hTERT mutant with the conserved aspartic acid residue at 788 required for reverse transcriptase activity mutated to asparagine (hTERT D788N), resulted in signi®cant decreases of telomerase activity, to at most half that seen in control cells. Measurement of telomeric restricted fragments (TRF) re¯ecting the size or length of telomeric DNA repeats showed no change between groups of dierentially transfected cells 24 h post transfection (not shown), while the TRF from PMC42 cells were con®rmed shorter than MCF7 cells ). However, a signi®cant increase in apoptosis was observed in the cell cultures expressing hTERT antisense RNA and decreased telomerase activity, but not in the cells expressing increased hTERT D788N mutant and decreased telomerase activity (Figure 1b) . These data are consistent with the ®ndings that lowering telomerase induces apoptosis within a relatively short time course independent of telomere shortening Saretzki et al., 2001) and in contrast to the observations that inhibition of telomerase activity over a long time course induces telomere shortening and cellular senescence (reviewed in (Liu, 2000) ). Thus, the divergence in telomerase inhibition and apoptosis induction between the cells with down-regulated hTERT and the cells with overexpressed hTERT mutant lacking telomerase activity points to a function of hTERT underlying cell survival in addition to its catalyst function in reverse transcription of telomeric DNA.
Increased genomic vulnerability and susceptibility to apoptosis induced by down-regulating endogenous hTERT was re¯ected by the increased sensitivity to stress and cell death of the cultured cells with lowered hTERT expression when exposed to G418 treatment for 24 ± 72 h. After 24 h of treatment increased cell death was observed in cell cultures with lowered hTERT expression and telomerase activity; after 72 h, massive cell loss was observed (Figure 1c ), suggesting that expression of endogenous hTERT is required for genome integrity and cell survival of cultured breast cancer cells. The pro-survival role of hTERT was further strengthened by demonstration that overexpression of hTERT resulted in increased survival of antibiotic treated cells. To compare the eect on cell death of lowering hTERT with that mediated by alterations in the p53 pathway, p53 was over-and under-expressed in PMC42 cells. Transient transfection of p53 antisense RNA induced signi®cant cell death; transient overexpression of p53 wild type for 24 h resulted in higher cell survival levels than in vector transfected controls (Figure 1c) , con®rming that p53 operates to protect the cells probably against genome instability (Morris et al., 2000) .
To further the mechanisms underlying cell death induced by lowering hTERT and inhibiting telomerase activity, cells were dierentially transfected with hTERT antisense RNA or hTERT mutant D788N for 15 h, followed by a second round expression of hTERT wild type and mutant. Expression of hTERT antisense RNA or hTERT mutant D788N for 15 h both inhibited telomerase activity ( Figure 1a) ; hTERT D788N expression, however, did not induce signi®cant cell death compared with vector only control or hTERT antisense RNA (Figure 2a ). Overexpression of wild type hTERT completely reversed the cell death induced by lowering hTERT with hTERT antisense RNA. Importantly, expression of the hTERT mutant D788N that lacks telomerase enzymatic activity also abolished hTERT down-regulation-induced cell death ( Figure 2a ). Thus, dominant negative inhibition of telomerase with an enzymatically activity-dead mutant of hTERT did not induce cell death in a short period of time, and replacement of endogenous hTERT with the hTERT mutant eectively rescued the cells from entering apoptosis induced by lowering endogenous hTERT.
Since hTERT and p53 produced a similar outcome in terms of cell survival (Figure 1c ), we tested if the eect of hTERT antisense RNA on cell death might be p53 regulated by co-transfecting hTERT antisense RNA in combination with p53 wild type or p53 antisense RNA. Expression of p53 wild type for 24 h prior to hTERT antisense RNA expression clearly prevented subsequent hTERT antisense expressioninduced cell death (Figure 2b, c) , suggesting that the genomic damage induced by lowering hTERT is abrogated by p53 overexpression. Conversely, expression of p53 antisense RNA enhanced the pro-apoptotic eect of hTERT antisense RNA, resulting in arrest of cell proliferation, cellular senescence and massive cell loss (Figure 2b, c) . These data are consistent with our recent ®ndings in vascular smooth muscle cells where over-or under-expression of p53 modulates the action of hTERT in cell survival and apoptosis . These indications of a functional interaction between hTERT and p53 are consistent with the conclusion that hTERT serves a pro-survival cellular To further explore the actions of hTERT, we compared hTERT subcellular distribution with that of p53 during cell division by indirect immuno¯uor-escent staining with speci®c antibodies (Li et al., 1998) . Speci®c staining of hTERT was con®rmed to be in the nucleus of interphase breast cancer cells (Figure 3 ) and speci®city of staining was con®rmed by the addition of antigenic peptide (not shown) and other controls . The subcellular distribution of hTERT during apoptosis changed in a pattern overlapping with, but not identical to, that of p53, as suggested by a degree of co-localization under immuno¯uorescent microscopy. As shown in Figure 3 , while prophase chromosomes were condensed, hTERT and p53 became dissociated from chromosomes. In metaphase, the majority of hTERT and p53 became distributed to the positions potentially interacting with microtubule spindles, consistent with previous ®ndings that p53 binds to microtubule spindles in three dierent human cell lines (Morris et al., 2000) . In anaphase, the twodaughter chromatids were separated and hTERT and p53 were seen to surround the chromatids with substantial amounts of hTERT and p53 at the equatorial plate. Approaching telophase, the signals diused to return to an even distribution in the nucleus at interphase (Figure 3 ). These data suggest a possible novel function for hTERT in chromosome partition by acting on microtubule spindles during mitosis, which may cooperate with and/or be regulated by p53.
The subcellular co-localization of hTERT and p53 and the previous ®ndings that p53 binds human telomerase-associated protein 1 (hTEP1) are consistent with the hypothesis of complex interactions between telomerase proteins and p53 under particular conditions (Li et al., 1999) . To further determine a possible interaction between hTERT and p53, we produced GST-p53 fusion proteins and performed an in vitro protein pull-down assay. As shown in Figure 4 , incubation of two dierent amounts of GST-p53 (5 and 20 mg) with nuclear protein extracts from human breast cancer cells produced a protein complex containing the hTERT (a), hTEP1 (b) and poly(ADPribose) polymerase (PARP) (c) revealed by Western blotting. The speci®c binding of PARP to p53 is consistent with previous studies (Wesierska-Gadek and Schmid, 2000) and serves a positive control. The binding of telomerase to GST-p53 was also speci®c in that it was competitively inhibited by excess recombinant p53 (not shown); GST protein only produced no binding of hTERT and hTEP1, as a negative control (Figure 4) . The ®nding that telomerase binds GST-p53 is also consistent with our previous ®nding that p53 coimmunoprecipitates with telomerase (Li et al., 1999) . Since both telomerase and PARP bind to GST-p53, we explored a possible in vivo interaction between telomerase and PARP by immunoprecipitation. Incubation of untransfected human breast cancer cell lysates with speci®c antibodies against hTERT, hTEP1 and PARP produced speci®c precipitation of PARP Figure 4d , a fraction of PARP co-immunoprecipitated with both hTERT and hTEP1. These data are in agreement with the recent ®ndings that PARP binds hTERT (962 ± 983) peptide directly (Pleschke et al., 2000) , and suggest for the ®rst time that telomerase interacts with PARP in intact breast cancer cells to regulate cell survival and proliferation.
Discussion
Telomerase is vital in proliferation of embryonic cells, recruitment of immune cells, expansion of bone marrow blood cell progenitors and immortalization of neoplastic cells, with the enzymatic activity of telomerase central to these cellular functions by the maintenance of telomeres. The enzymatic activity of telomerase is dependent upon hTERT, the catalyst moiety of the telomerase holoenzyme. In the present study, we demonstrate a novel function for hTERT in maintaining genomic integrity and promoting cell survival, over and above telomerase enzymatic activity in telomere lengthening. The telomerase activityindependent, pro-survival, anti-apoptotic role of hTERT was shown by three distinct experiments on human breast cancer PMC42 cells. First, downregulating hTERT expression causes apoptosis that is telomere shortening-independent, as is mirrored by the inability of telomerase activity-null hTERT mutant (hTERT D788N) that does not induce apoptosis within the same time course of 24 h of gene expression. Second, the hTERT D788N mutant eectively rescues otherwise apoptotic cells induced by hTERT down regulation. Third, apoptosis by lowering hTERT is completely prevented by increasing p53 and markedly enhanced by decreasing p53. Taken together, these data indicate that in addition to its catalytic activity in telomeric DNA reverse transcription to lengthen telomeric DNA, hTERT also protects genomic DNA by physical interactions independent of its catalytic enzymatic activity in human cells. The pro-cellular survival function of hTERT is consistent with recent ®ndings that hTERT possesses an anti-apoptotic role in cultured neurons (Zhu et al., 2000) , cardiac muscle cells (Oh et al., 2001 ) and vascular smooth muscle cells , and with the hypothesis that telomerase has a telomere capping function that is independent from telomere lengthening (Blackburn, 2000) and that telomerase is involved in complex interactions with other signaling pathways (Liu, 2000) . Thus, telomerase is crucial once activated in regulating and maintaining both cell survival and proliferation not only by its enzymatic eect on telomeric DNA synthesis but also by physical interactions to protect genome stability in continuously and discontinuously dividing cells. The exact action(s) of hTERT in the telomerase activity-independent anti-apoptotic function are still unknown. Since it interacts with the single strand telomeric DNA overhangs, hTERT may participate in capping telomeres separable from telomeric DNA lengthening activity (Blackburn, 2000) . The presented data may thus constitute important evidence to substantiate the concept of telomerase capping function at telomeres. It is possible that hTERT may also regulate telomeric tertiary structures, protecting telomeres from being damaged, degraded or fused with other telomeres in addition to elongating telomeric DNA by reverse transcription. Given that telomeres form large duplex loops with their 5' overhangs invading and being buried in-between double-stranded telomeres (Grith et al., 1999) , it has been hypothesized that hTERT plays a role in regulating telomere loop closing, and of protecting telomeres in unclosed loops Liu, 2001 ). In addition, immuno¯uorescent staining for hTERT in the present study also shows that hTERT starts to dissociate from chromosomes in mitotic prophase, and may then bind to microtubule spindles at metaphase, followed by localizing around the daughter chromatids in anaphase. These data also suggest for the ®rst time that hTERT carries out molecular actions other than regulating telomere structures, and is potentially involved in the G2/M mitotic spindle function and checkpoint in mitosis.
Consistent with previous ®ndings that p53 is also involved in mitotic spindle function in human cells (Morris et al., 2000) and co-immunoprecipitates with telomerase from breast cancer cells (Li et al., 1999) , the present study shows that p53 shares a similar subcellular distribution pattern with that of hTERT under immuno¯uorescent microscopy throughout mitosis. It may thus be possible that hTERT and p53 cooperate to maintain normal mitotic spindle function during chromosome segregation. In support of a possible interaction between hTERT and p53 is the ®nding that hTERT binds to GST-p53 in broken cells (Figure 4 ). In addition, hTERT and p53 functionally interact in that p53 modulates breast cancer cell survival or apoptosis induced by lowering hTERT gene expression. This functional interaction between hTERT and p53 may not be limited to the breast cancer cells only, as we have also observed similar interactions consistently in cultured vascular smooth muscle cells . The mechanism whereby p53 rescues hTERT-induced genomic damage and Figure 4 Protein ± protein interactions between telomerase, p53 and PARP. (a) hTERT binds GST-p53. Nuclear lysates of breast cancer cells were incubated with GST-p53 for 1 h at 48C and speci®c protein binding to GST-p53 was resolved in the GST-p53 precipitates after extensive washing by immunoblotting with rabbit anti-hTERT polyclonal anity-puri®ed antibodies. (b) hTEP1 binds GST-p53. GST-p53 precipitates from incubation with the nuclear protein extracts were probed with rabbit anti-TEP1 polyclonal anity-puri®ed antibodies. (c) PARP binds to GST-p53. GST-p53 precipitates from incubation with the nuclear protein extracts were probed with mouse anti-human PARP puri®ed monoclonal antibodies. (d) PARP co-immunoprecipitates with telomerase. Breast cancer cell nuclear lysates were subject to immunoprecipitation with the antibodies indicated and the immunoprecipitates probed with anti-PARP antibody. Results are representative of three separate similar experiments apoptosis requires further investigation. The ®nding that transient expression of wild type p53 is associated with increased cell numbers (Figures 1c and 2c) suggests that many cells were not arrested within 24 h by p53 transcriptional activity, and that the increased cell number may at least in part re¯ect decreased cell death. However, the possibility that p53 induces proliferative arrest thereby reducing chromosome end-to-end fusion and the fusion-induced mitotic catastrophes cannot be excluded. It is also possible that the genomic stability aected by hTERT downregulation is reversible, and that activation of p53 contributes to repair of the damaged genome by both transcription-dependent and -independent activity. It also cannot be ruled out that both proteins may operate at the G2/M mitotic spindle checkpoint in mitosis. Increased expression of p53 may thus counterbalance hTERT down regulation-induced alterations of the cellular mitotic machinery and genomic vulnerability during mitosis, thereby ensuring cell survival and proliferation. When p53 expression is decreased, the genomic damage triggered by hTERT downregulation is exacerbated and severe cell death follows. This eect of p53 is unlikely to result from modulation of telomerase enzymatic activity in terms of telomere lengthening, as p53 is shown to inhibit telomerase activity at both protein (Li et al., 1999) and gene expression levels (Xu et al., 2000) .
In addition, the present study provides evidence for the ®rst time that the telomerase complex interacts with the DNA damage signal protein PARP, and suggests possible interactions among telomerase proteins, p53 and PARP in human breast cancer cells. This is consistent with the recent ®ndings that poly(ADPribose) mediates the binding of PARP to p53 and hTERT (962 ± 983) peptide (Pleschke et al., 2000) . It may be possible that telomerase, p53 and PARP undergo molecular interactions involving poly(ADPribose) chains under particular conditions to protect genomic integrity and allow repair of chromosomal DNA damage in vivo. It is feasible that in response to DNA damage, PARP produces poly(ADP-ribose) chains that serve as local focal intermediates mediating hTERT protein ± protein interactions in rapidly dividing cancer cells. Since the poly(ADP-ribose) binding site overlaps the nuclear export signal (NES) in hTERT, it is also possible that poly(ADP-ribose) produced in response to DNA damage masks NES of hTERT, thereby preventing hTERT from being exported out of nucleus with damaged genomic DNA, and thus allowing hTERT to participate in the maintenance of genome integrity. In summary, we demonstrate for the ®rst time a novel pro-survival action of hTERT independent of telomerase enzymatic activity and involving molecular interactions with p53 and PARP in human breast cancer cells. Thus, hTERT is not only sucient to catalyze telomeric DNA reverse transcription in promoting cell proliferative lifespan but also important for cell survival involving complex intermolecular interactions both within and beyond the telomerase ribonucleoprotein complex.
Materials and methods

Expression construct preparation and cellular transfection
The hTERT (human telomerase reverse transcriptase) and p53 wild type plasmids were prepared by subcloning fulllength cDNAs into pcDNA3HA plasmids respectively. hTERT antisense expression vectors were generated by subcloning two hTERT cDNA fragments (1 ± 2493 and 1 ± 3399) into pcDNA3HA vectors in antisense direction. The single amino acid mutation of hTERT (D788N) was prepared by mutagenic oligonucleotide-mediated PCR followed by removal of parental wild type template DNA plasmid. P53 antisense expression plasmids were prepared by subcloning the full-length p53 into pcDNA3HA in the antisense direction. All constructs were veri®ed by restriction enzyme digestion ®rst and subsequently by DNA sequencing. The empty vector control, wild type, mutated and antisense expression constructs were transfected into cultured human breast cancer PMC42 cells at about 80% con¯uence with Lipofectamine 2000 (6 m1/2 mg DNA/1 ml). After 24 h incubation, cells were observed, examined for various changes, or subcultured at various densities for additional transfection or treatments as indicated in the ®gure legends of each particular experiment. For double transfection, cells were transfected for 15 ± 24 h followed by a second transfection for 24 h, with speci®c expression constructs as speci®ed in individual experiments. The transfection eciency is around 40% as determined by immuno¯uorescent microscopy.
Phase-contrast microcopy, immunofluorescent staining and TUNEL
Transfected cells were observed by phase-contrast microscopy for cell death and viability, and microphotographs were taken at various times following gene delivery. Cell numbers were counted in cell suspension by Z 2 Coulter Particle Count & Size Analyzer (Coulter Corporation, Miami, Fl. 3196 ± 2500) and living cells attached to dishes were stained by crystal blue. Immuno¯uorescent staining for subcellular localization of hTERT and p53 in non-transfected PMC42 cells was performed as described elsewhere with anity-puri®ed rabbit anti-TERT polyclonal antibodies and commercial anti-p53 monoclonal antibodies; the speci®city of the anti-TERT antibodies has also been demonstrated previously Li et al., 1998; Yang et al., 2001) . No cross activity was detected between primary antibodies or between secondary antibodies in the indirect immuno¯uorescent microscopy. TUNEL (TdT-mediated dUTP-X nick end labeling) was carried out with standard protocols by incubating ®xed and permeabilized transformants in the presence or absence of terminal transferase,¯uorescein-dUTP in appropriate buer. Positive and negative controls were included in each experiment. Fluorescent labeling of speci®c antigens or broken chromosomal DNA was observed bȳ uorescent microscopy.
GST fusion proteins, in vitro binding assay and immunoblotting
The expression plasmids pET11-GST-p53 and pET11-GST were individually transduced into E. coli and gene expression induced by IPTG at room temperature. Expressed recombinant GST and GST-p53 fusion proteins puri®ed on glutathione beads were incubated with nuclear protein extracts of breast cancer PMC42 cells for 1 h at 48C and after extensive washing, proteins bound to the recombinant proteins were resolved on SDS ± PAGE and visualized by immunoblotting with anity-puri®ed polyclonal anti-TERT (Li et al., 1998) . Expression of other proteins was determined by immunoblotting using antibodies against p53 (FL-393, sc-6243, Santa Cruz) and poly(ADP-ribose) polymerase (PARP) (66401A, M041049, ParMingen).
Telomerase activity assay and telomere length analysis A TRAP assay, performed essentially as described previously (Li et al., 1997) , was employed to determine telomerase activity. Brie¯y, equal amounts of nuclear telomerase extracts (0.5 mg) were incubated with telomeric DNA substrate and dNTP and de novo synthesized telomeres were ampli®ed by PCR and the resultant 32 P-labeled products resolved by polyacrylamide slab gel electrophoresis followed by autoradiography. An internal control was used to monitor for non-speci®c PCR eects by including additional primers NT (ATCGCTTCTCGGCCTTTT) and TSNT (AATCCG-TCGAGCAGAGTTAAAAGGCCGAGAAGCGAT). Negative controls treated with either RNase-A or alkaline phosphatase to inactivate telomerase were included in each experiment assessing telomerase activity. Telomere length was determined by extracting chromosome DNA, digesting with the restriction enzymes HinfI and RsaI (50 U; 378C overnight), followed by phenol/chloroform extraction and Southern blotting with radioisotope-labeled telomeric DNA as a probe, as described elsewhere (Bryan et al., 1995) .
Abbreviations TERT, telomerase reverse transcriptase; PARP, poly(ADPribose) polymerase.
